ICD-10-CM Billable Code

L74.51

Primary focal hyperhidrosis

Clinical Classification Guidelines

Medical Intelligence & Overview

Primary focal hyperhidrosis is a condition characterized by excessive sweating that occurs in specific areas of the body without an apparent reason. This condition often affects the palms of the hands, soles of the feet, face, and underarms. Unlike general sweating that helps regulate body temperature, hyperhidrosis involves abnormal overproduction of sweat due to overactive sweat glands. It can significantly impact daily life, causing discomfort, emotional distress, and social challenges.

Causes & Symptoms

Clinical Causes: Disruption in the nerve signals that stimulate sweat glands, leading to excessive sweating in localized areas. Genetic predisposition, with a tendency to develop similar symptoms within families. No identifiable underlying medical condition causing the excessive sweating, which differentiates primary hyperhidrosis from secondary forms. Possible overactivity of the sympathetic nervous system, which controls sweat production. Environmental or emotional factors may exacerbate symptoms but are not direct causes.

Key Symptoms: Persistent and excessive sweating in specific areas, often bilateral (affecting both sides equally). Sweating that occurs even without physical activity or high temperatures. Clammy or moist skin in the affected regions. Potential skin irritation or infections due to constant moisture. Interference with daily activities, such as gripping objects or handling tools. Emotional distress, anxiety, or embarrassment caused by visible sweating or odor. In some cases, skin may develop calluses or infections if sweating is persistent and untreated.

Diagnostic & Treatment

Diagnosis Path: Diagnosis is mainly clinical, based on patient history and physical examination. Healthcare providers look for characteristic patterns of sweating and rule out other causes. Tests such as starch-iodine tests or gravimetric sweat measurements may be used to confirm hyperhidrosis and identify affected areas. Additional evaluations might be conducted to exclude secondary hyperhidrosis caused by underlying medical conditions, medications, or hormonal imbalances.

Treatment Protocols: Management of primary focal hyperhidrosis includes several approaches aimed at controlling symptoms: - **Topical treatments:** Use of antiperspirants containing aluminum chloride to reduce sweat production. - **Iontophoresis:** A procedure that uses electrical currents to decrease sweating, especially effective for palms and soles. - **Medications:** Oral anticholinergic drugs may be prescribed to inhibit sweat glands, though they may have side effects. - **Botulinum toxin (Botox) injections:** Blocks nerve signals to sweat glands, providing relief lasting several months. - **Surgical options:** In severe cases, procedures such as sympathectomy or removal of sweat glands might be considered, but these carry risks and are generally last-resort options. Early intervention can help reduce discomfort and improve quality of life. Patients are encouraged to discuss symptoms and treatment options with healthcare professionals experienced in managing hyperhidrosis.

Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes.

Clinical Advice & FAQs

Billing Guidance

Is L74.51 a billable ICD-10 code?
Yes, L74.51 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.

Documentation

How do I report L74.51?
Clinical documentation must specify the nature of Primary focal hyperhidrosis and any associated comorbidities for accurate reporting.

Cite this Clinical Reference

Clinical Meta Tags

hyperhidrosis primary focal